Volume | 62,576 |
|
|||||
News | - | ||||||
Day High | 0.748 | Low High |
|||||
Day Low | 0.695 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Cingulate Inc | CING | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.748 | 0.695 | 0.748 | 0.701 | 0.7172 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
259 | 62,576 | US$ 0.7126197 | US$ 44,593 | - | 0.65 - 21.80 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
16:37:58 | 20 | US$ 0.73 | USD |
Cingulate Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
655.9k | 937.00k | - | 0 | -23.54M | -25.12 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cingulate News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CING Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.8066 | 0.8465 | 0.65 | 0.7255501 | 179,053 | -0.0866 | -10.74% |
1 Month | 1.14 | 1.1499 | 0.65 | 0.8218517 | 438,925 | -0.42 | -36.84% |
3 Months | 1.22 | 1.35 | 0.65 | 0.9254553 | 239,747 | -0.50 | -40.98% |
6 Months | 6.42 | 12.70 | 0.65 | 4.87 | 952,281 | -5.70 | -88.79% |
1 Year | 19.40 | 21.80 | 0.65 | 7.22 | 628,824 | -18.68 | -96.29% |
3 Years | 100.00 | 103.00 | 0.65 | 18.42 | 412,280 | -99.28 | -99.28% |
5 Years | 100.00 | 103.00 | 0.65 | 18.42 | 412,280 | -99.28 | -99.28% |
Cingulate Description
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. |